| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 6.18 MB | Adobe PDF |
Orientador(es)
Resumo(s)
The capabilities of bioanalytical mass spectrometry to (i) detect and differentiate viruses at the peptide level whilst maintaining high sample throughput and (ii) to provide diagnosis and prognosis for infected patients are presented as a tutorial in this work to aid analytical chemists and physicians to gain insights into the possibilities offered by current high-resolution mass spectrometry technology and bioinformatics. From (i) sampling to sample treatment; (ii) Matrix-Assisted Laser Desorption Ionization- to Electrospray Ionization -based mass spectrometry; and (iii) from clustering to peptide sequencing; a detailed step-by-step guide is provided and exemplified using SARS-CoV-2 Spike Y839 variant and the variant of concern SARS-CoV-2 Alpha (B.1.1.7 lineage), Influenza B, and Influenza A subtypes AH1N1pdm09 and AH3N2.
Descrição
PM003/2016). The authors acknowledge Dr. Miguel Fevereiro from INIAV for his valuable help and fruitful discussions.
Publisher Copyright:
© 2022 The Author(s)
Palavras-chave
Immuno-mass spectrometry LC-ESI-Q-TOF-MS/MS MALDI-TOF-MS Viral detection Analytical Chemistry Spectroscopy
